MDLZ · Q2 2025 Earnings

Insufficient prior-coverage history to draw a multi-quarter arc, but the tone within this call shifted notably versus Mondelez's usual register. Three specific shifts stand out.

From "pricing power as primary lever" to "surgical pricing with volume risk as co-equal lever." After two years of leaning on pricing to absorb cocoa costs, management this quarter explicitly named the $3-$4 per-pack price point as a defensive line that cannot be crossed: "between $3 and $4 per pack, it is the magic...We will protect those price points...there is a whole host of ideas as to what we have to do to boost consumption in the second half, particularly as it boils down to RGM and promotions." That is a meaningful concession that the pricing-only algorithm has reached its ceiling and that promotional reinvestment is coming.

From "guidance as predictable execution" to "guidance maintained but acknowledged as fragile." The phrase "I'm not suggesting that the guidance is slam dunk at this point in time," paired with "we have less flexibility...the unprecedented heat wave that impacted chocolate in Europe is clearly something we couldn't predict, as well as the impact we had particularly in the US because of the trade, the stocking," is unusually candid for Mondelez. It signals that the buffer for additional shocks has been spent and any further negative surprise likely forces a cut.

From "cocoa decline as base case" to "two-scenario planning with no clear direction." On 2026 cocoa: "this is one of the unknowns of the plan...there are possibly two scenarios. One is it stays elevated, but the other one is it might go down quite rapidly." Management is no longer underwriting cocoa normalization as the planning base — they are explicitly preparing for a bimodal outcome, with a hint that additional pricing may be needed if cocoa stays high.

The North America narrative also hardened. Management moved from treating North American softness as a transient consumer pause to a structural issue requiring sustained reinvestment: "I'm not expecting that that immediately will be better next year. So I'm expecting that we will have to increase our investment in our brands also in North America next year." That is a forward operating-cost commitment with no offsetting growth claim — read it as a small implicit cut to 2026 margin expectations.

On GLP-1, management was firmer and more dismissive than in prior commentary: a quantified rebuttal ("4% of the population reducing their calorie intake by 11%, that is a 0.4% effect on the total population") and "no real impact on our volumes." Read this as defensive — they need investors to believe the volume weakness is cyclical, not categorically structural.